S glycoprotein Subunit1, S1 protein, Spike, Spike protein S1, sars-cov-2
The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.
Molecular Weight:
77.9 kDa (predicted). Due to glycosylation, the protein migrates to 110-120 kDa based on Tris-Bis PAGE result.
Purity:
>95%
TMPK-00436
* VAT and and shipping costs not included. Errors and price changes excepted
